Update on cenobamate: long-term and subgroup analyses

Update on cenobamate: long-term and subgroup analyses

Cenobamate was approved by the FDA in 2019 and the EMA in 2021 for the adjunctive treatment of focal-onset seizures with or without secondary generalization in adult patients. Following its approval, studies have continued to further investigate long-term safety and effectiveness.

In this podcast, William E. Rosenfeld and Pavel Klein share new data from open-label extensions and subgroup analyses, as well as practical recommendations for its use in clinical practice.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(55)

The impact of climate change on neurological diseases

The impact of climate change on neurological diseases

In this episode, we bring you a discussion recorded at EAN 2026 exploring the growing impact of climate change on neurological health. The panel discusses evidence linking rising temperatures and envi...

28 Sep 13min

Advancing the treatment of myasthenia gravis: current and emerging therapies

Advancing the treatment of myasthenia gravis: current and emerging therapies

Welcome to this episode of the VJNeurology Podcast, where leading experts will explore some of the latest advances in the treatment of myasthenia gravis, discussing emerging therapeutic strategies and...

18 Sep 21min

Life after Stroke: Practical strategies for secondary prevention and rehabilitation

Life after Stroke: Practical strategies for secondary prevention and rehabilitation

Episode 2 of our Life after Stroke roundtable discussion series is now available as a podcast! In this exclusive discussion, leading experts Aristeidis Katsanos, MD, PhD, McMaster University, Hamilton...

11 Sep 1h 11min

Orexin agonists in narcolepsy: current evidence and future directions

Orexin agonists in narcolepsy: current evidence and future directions

In this episode of the VJNeurology Podcast, we explore the rapidly evolving landscape of orexin agonists for the treatment of narcolepsy. Following the recent FDA approval of oveporexton, as well as n...

4 Sep 20min

Life after Stroke: First steps in secondary stroke prevention

Life after Stroke: First steps in secondary stroke prevention

Episode 1 of our Life after Stroke roundtable discussion series is now available as a podcast! In this exclusive discussion, leading experts Aristeidis Katsanos, MD, PhD, McMaster University, Hamilton...

28 Aug 55min

Advances in sleep medicine and research from SLEEP 2026

Advances in sleep medicine and research from SLEEP 2026

This episode of the VJNeurology Podcast showcases advances across insomnia, restless legs syndrome, narcolepsy, and sleep apnea from SLEEP 2026. Leading experts discuss updates to the American Academy...

10 Jul 41min

AAN 2026 highlights: key trial updates across narcolepsy, movement disorders, Tourette syndrome & more!

AAN 2026 highlights: key trial updates across narcolepsy, movement disorders, Tourette syndrome & more!

This episode of the VJNeurology Podcast showcases key trial updates from the American Academy of Neurology Annual Meeting in Chicago, IL. Highlights include orexin receptor agonists for narcolepsy, AM...

5 Mai 32min

Pediatric sleep disturbances: impact, screening, and ongoing research

Pediatric sleep disturbances: impact, screening, and ongoing research

This episode of the VJNeurology Podcast features a discussion with Prof. Karen Spruyt, PhD, Université Paris Cité, INSERM, NeuroDiderot, Paris, on pediatric sleep disturbances. Prof. Spruyt shares her...

11 Mar 27min

Populært innen Helse

fastlegen
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
foreldreradet
morten-ramm-lar-kakla-ga-til-du-sovner
rss-lopedrommen
treningsprat
g-punktet
klimaks
kjed-deg-i-sovn-verdens-kjedeligste-podcast
hjernesterk
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-loping-for-nybegynnere
hverdagspsyken
helsetipspodden
apent-forhold